Mutations in AXIN2 cause colorectal cancer with defective mismatch repair by activating β-catenin/TCF signalling

被引：426
|
作者：
Liu, WG [1 ]
Dong, XY [1 ]
Mai, M [1 ]
Seelan, RS [1 ]
Taniguchi, K [1 ]
Krishnadath, KK [1 ]
Halling, KC [1 ]
Cunningham, JM [1 ]
Qian, CP [1 ]
Christensen, E [1 ]
Roche, PC [1 ]
Smith, DI [1 ]
Thibodeau, SN [1 ]
机构：
[1] Mayo Clin & Mayo Med Sch, Dept Lab Med & Pathol, Div Expt Pathol, Rochester, MN 55905 USA
来源：
NATURE GENETICS | 2000年 / 26卷 / 02期
关键词：
D O I：
10.1038/79859
中图分类号：
Q3 [遗传学];
学科分类号：
071007 ; 090102 ;
摘要：
[No abstract available]
引用
收藏
页码：146 / 147
页数：2
相关论文
共 50 条
  • [21] Mutations in AXIN2 gene as a risk factor for tooth agenesis and cancer: A review
    Hlouskova, Alena
    Bielik, Peter
    Bonczek, Ondrej
    Balcar, Vladimir J.
    Sery, Omar
    NEUROENDOCRINOLOGY LETTERS, 2017, 38 (03) : 131 - 137
  • [22] Pharmacological targeting of Axin2 suppresses cell growth and metastasis in colorectal cancer
    Cheng, Li-Zhi
    Huang, Dan-Ling
    Tang, Zhang-Rui
    Zhang, Jia-Hao
    Xiong, Ting
    Zhou, Chen
    Zhang, Nai-Xia
    Fu, Rong
    Cheng, Yong-Xian
    Wu, Zhao-Qiu
    BRITISH JOURNAL OF PHARMACOLOGY, 2023, 180 (23) : 3071 - 3091
  • [23] AXIN2 germline testing in a French cohort validates pathogenic variants as a rare cause of predisposition to colorectal polyposis and cancer
    Leclerc, Julie
    Beaumont, Marie
    Vibert, Roseline
    Pinson, Stephane
    Vermaut, Catherine
    Flament, Cathy
    Lovecchio, Tonio
    Delattre, Lucie
    Demay, Christophe
    Coulet, Florence
    Guillerm, Erell
    Hamzaoui, Nadim
    Benusiglio, Patrick R.
    Brahimi, Afane
    Cornelis, Francois
    Delhomelle, Helene
    Fert-Ferrer, Sandra
    Fournier, Benjamin P. J.
    Hovnanian, Alain
    Legrand, Clementine
    Lortholary, Alain
    Malka, David
    Petit, Florence
    Saurin, Jean-Christophe
    Lejeune, Sophie
    Colas, Chrystelle
    Buisine, Marie-Pierre
    GENES CHROMOSOMES & CANCER, 2023, 62 (04): : 210 - 222
  • [24] An aggregon in conductin/axin2 regulates Wnt/β-catenin signaling and holds potential for cancer therapy
    Dominic B. Bernkopf
    Martina Brückner
    Michel V. Hadjihannas
    Jürgen Behrens
    Nature Communications, 10
  • [25] An aggregon in conductin/axin2 regulates Wnt/β-catenin signaling and holds potential for cancer therapy
    Bernkopf, Dominic B.
    Brueckner, Martina
    Hadjihannas, Michel V.
    Behrens, Juergen
    NATURE COMMUNICATIONS, 2019, 10 (1)
  • [26] DEFECTIVE-DNA MISMATCH REPAIR AS A CAUSE OF COLON-CANCER
    LINDBLOM, A
    TANNERGARD, P
    NORDENSKJOLD, M
    PATHOLOGIE BIOLOGIE, 1994, 42 (10): : 1059 - 1060
  • [27] Mismatch repair defective breast cancer in the hereditary nonpolyposis colorectal cancer syndrome
    Jensen, Uffe Birk
    Sunde, Lone
    Timshel, Susanne
    Halvarsson, Britta
    Nissen, Anja
    Bernstein, Inge
    Nilbert, Mef
    BREAST CANCER RESEARCH AND TREATMENT, 2010, 120 (03) : 777 - 782
  • [28] Mismatch repair defective breast cancer in the hereditary nonpolyposis colorectal cancer syndrome
    Uffe Birk Jensen
    Lone Sunde
    Susanne Timshel
    Britta Halvarsson
    Anja Nissen
    Inge Bernstein
    Mef Nilbert
    Breast Cancer Research and Treatment, 2010, 120 : 777 - 782
  • [29] Mismatch repair, p53 and β-catenin proteins in colorectal cancer
    Valentini, AM
    Renna, L
    Armentano, R
    Pirrelli, M
    Di Leo, A
    Gentile, M
    Caruso, ML
    ANTICANCER RESEARCH, 2002, 22 (04) : 2083 - 2088
  • [30] Rare germline variants in the AXIN2 gene in families with colonic polyposis and colorectal cancer
    Chan, James M.
    Clendenning, Mark
    Joseland, Sharelle
    Georgeson, Peter
    Mahmood, Khalid
    Walker, Romy
    Como, Julia
    Joo, Jihoon E.
    Preston, Susan
    Hutchinson, Ryan A.
    Pope, Bernard J.
    Metz, Andrew
    Beard, Catherine
    Purvis, Rebecca
    Arnold, Julie
    Vijay, Varnika
    Konycheva, Galina
    Atkinson, Nathan
    Parry, Susan
    Jenkins, Mark A.
    Macrae, Finlay A.
    Rosty, Christophe
    Winship, Ingrid M.
    Buchanan, Daniel D.
    FAMILIAL CANCER, 2022, 21 (04) : 399 - 413
12345